182 related articles for article (PubMed ID: 7908501)
1. Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness.
Rabkin JG; Rabkin R; Harrison W; Wagner G
Am J Psychiatry; 1994 Apr; 151(4):516-23. PubMed ID: 7908501
[TBL] [Abstract][Full Text] [Related]
2. Effects of fluoxetine on mood and immune status in depressed patients with HIV illness.
Rabkin JG; Rabkin R; Wagner G
J Clin Psychiatry; 1994 Mar; 55(3):92-7. PubMed ID: 7915270
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial.
Rabkin JG; Wagner GJ; Rabkin R
Am J Psychiatry; 1999 Jan; 156(1):101-7. PubMed ID: 9892304
[TBL] [Abstract][Full Text] [Related]
4. Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial.
Rabkin JG; Wagner G; Rabkin R
J Clin Psychiatry; 1994 Oct; 55(10):433-9. PubMed ID: 7961520
[TBL] [Abstract][Full Text] [Related]
5. Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program.
Sotsky SM; Glass DR; Shea MT; Pilkonis PA; Collins JF; Elkin I; Watkins JT; Imber SD; Leber WR; Moyer J
Am J Psychiatry; 1991 Aug; 148(8):997-1008. PubMed ID: 1853989
[TBL] [Abstract][Full Text] [Related]
6. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
Cohn CK; Robinson DS; Roberts DL; Schwiderski UE; O'Brien K; Ieni JR
J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358
[TBL] [Abstract][Full Text] [Related]
7. Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial.
Nunes EV; Quitkin FM; Donovan SJ; Deliyannides D; Ocepek-Welikson K; Koenig T; Brady R; McGrath PJ; Woody G
Arch Gen Psychiatry; 1998 Feb; 55(2):153-60. PubMed ID: 9477929
[TBL] [Abstract][Full Text] [Related]
8. Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients.
Elliott AJ; Uldall KK; Bergam K; Russo J; Claypoole K; Roy-Byrne PP
Am J Psychiatry; 1998 Mar; 155(3):367-72. PubMed ID: 9501747
[TBL] [Abstract][Full Text] [Related]
9. A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression.
McGrath PJ; Stewart JW; Nunes EV; Ocepek-Welikson K; Rabkin JG; Quitkin FM; Klein DF
Am J Psychiatry; 1993 Jan; 150(1):118-23. PubMed ID: 8417553
[TBL] [Abstract][Full Text] [Related]
10. Imipramine is effective after unsuccessful cognitive therapy: sequential use of cognitive therapy and imipramine in depressed outpatients.
Stewart JW; Mercier MA; Agosti V; Guardino M; Quitkin FM
J Clin Psychopharmacol; 1993 Apr; 13(2):114-9. PubMed ID: 8463443
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine.
Kasper S; Möller HJ; Montgomery SA; Zondag E
Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():3-12. PubMed ID: 7622821
[TBL] [Abstract][Full Text] [Related]
12. A two-center double-blind study of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
Cohn JB; Varga L; Lyford A
J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):68-72. PubMed ID: 6370980
[TBL] [Abstract][Full Text] [Related]
13. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
Fabre LF
J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
[TBL] [Abstract][Full Text] [Related]
14. Comparison of alprazolam and imipramine for treatment of outpatient depression.
Overall JE; Biggs J; Jacobs M; Holden K
J Clin Psychiatry; 1987 Jan; 48(1):15-9. PubMed ID: 3542981
[TBL] [Abstract][Full Text] [Related]
15. Effect of imipramine on depression and immune status in a sample of men with HIV infection.
Rabkin JG; Harrison WM
Am J Psychiatry; 1990 Apr; 147(4):495-7. PubMed ID: 1969246
[TBL] [Abstract][Full Text] [Related]
16. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
Feighner JP; Boyer WF
J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
[TBL] [Abstract][Full Text] [Related]
17. Nefazodone in the treatment of severe, melancholic, and recurrent depression.
Marcus RN; Mendels J
J Clin Psychiatry; 1996; 57 Suppl 2():19-23. PubMed ID: 8626359
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
[TBL] [Abstract][Full Text] [Related]
19. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
Schweizer E; Feighner J; Mandos LA; Rickels K
J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
[TBL] [Abstract][Full Text] [Related]
20. Modafinil treatment for fatigue in HIV/AIDS: a randomized placebo-controlled study.
Rabkin JG; McElhiney MC; Rabkin R; McGrath PJ
J Clin Psychiatry; 2010 Jun; 71(6):707-15. PubMed ID: 20492840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
